Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Diffuse Large B-Cell Lymphoma (DLBCL)
Wuhan, Hubei
Diffuse Large B-Cell Lymphoma (DLBCL) Clinical Trials in Wuhan, Hubei
1 recruiting
Wuhan, Hubei, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.
150 enrolled
41 locations
NCT07189065
Feedback